Ivermectin
Sklice, Soolantra, Stromectol, Mectizan (ivermectin) is an unknown pharmaceutical. Ivermectin was first approved as Sklice on 1996-11-22. It is used to treat ascariasis, elephantiasis, enterobiasis, lice infestations, and mansonelliasis amongst others in the USA. It is known to target P2X purinoceptor 4, neuronal acetylcholine receptor subunit alpha-7, P2X purinoceptor 7, and gamma-aminobutyric acid receptor subunit beta-3. Stromectol's patents are valid until 2034-03-13 (FDA).
| Trade Name | Mectizan |
|---|---|
| Common Name | Ivermectin |
| ChEMBL ID | CHEMBL1200633 |
| Indication | ascariasis, elephantiasis, enterobiasis, lice infestations, mansonelliasis, onchocerciasis, scabies, strongyloidiasis, trichuriasis |
| Drug Class | Antiparasitics (ivermectin type) |
